First National Bank Sioux Falls’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,050
| Closed | -$214K | – | 134 |
|
|
2024
Q4 | $214K | Sell |
8,050
-565
| -7% | -$15.3K | 0.09% | 126 |
|
|
2024
Q3 | $249K | Buy |
8,615
+50
| +0.6% | +$1.46K | 0.11% | 117 |
|
|
2024
Q2 | $240K | Buy |
+8,565
| New | +$236K | 0.12% | 117 |
|
|
2023
Q4 | – | Sell |
-7,968
| Closed | -$264K | – | 129 |
|
|
2023
Q3 | $264K | Sell |
7,968
-750
| -9% | -$26.5K | 0.16% | 107 |
|
|
2023
Q2 | $320K | Buy |
8,718
+600
| +7% | +$23.4K | 0.2% | 91 |
|
|
2023
Q1 | $331K | Sell |
8,118
-200
| -2% | -$8.64K | 0.23% | 88 |
|
|
2022
Q4 | $426K | Sell |
8,318
-750
| -8% | -$36K | 0.31% | 71 |
|
|
2022
Q3 | $397K | Sell |
9,068
-2,000
| -18% | -$97.2K | 0.42% | 68 |
|
|
2022
Q2 | $580K | Sell |
11,068
-545
| -5% | -$27.8K | 0.74% | 50 |
|
|
2022
Q1 | $601K | Buy |
11,613
+100
| +0.9% | +$5.19K | 0.63% | 51 |
|
|
2021
Q4 | $680K | Buy |
11,513
+240
| +2% | +$11.9K | 0.73% | 45 |
|
|
2021
Q3 | $485K | Buy |
11,273
+250
| +2% | +$11.1K | 0.81% | 43 |
|
|
2021
Q2 | $432K | Buy |
11,023
+450
| +4% | +$17.5K | 0.66% | 46 |
|
|
2021
Q1 | $383K | Buy |
+10,573
| New | +$375K | 0.68% | 55 |
|
|
2020
Q4 | – | Sell |
-7,030
| Closed | -$245K | – | 75 |
|
|
2020
Q3 | $245K | Hold |
7,030
| – | – | 0.65% | 58 |
|
|
2020
Q2 | $218K | Hold |
7,030
| – | – | 0.63% | 59 |
|
|
2020
Q1 | $218K | Sell |
7,030
-106
| -1% | -$3.61K | 0.76% | 52 |
|
|
2019
Q4 | $265K | Buy |
+7,136
| New | +$254K | 0.73% | 53 |
|
|
2016
Q4 | – | Sell |
-3,549
| Closed | -$114K | – | 167 |
|
|
2016
Q3 | $114K | Buy |
3,549
+1,845
| +108% | +$61.7K | 0.31% | 62 |
|
|
2016
Q2 | $57K | Hold |
1,704
| – | – | 0.18% | 96 |
|
|
2016
Q1 | $48K | Sell |
1,704
-127
| -7% | -$3.63K | 0.16% | 101 |
|
|
2015
Q4 | $56K | Hold |
1,831
| – | – | 0.18% | 94 |
|
|
2015
Q3 | $55K | Sell |
1,831
-41
| -2% | -$1.31K | 0.18% | 94 |
|
|
2015
Q2 | $60K | Sell |
1,872
-30
| -2% | -$978 | 0.18% | 94 |
|
|
2015
Q1 | $63K | Buy |
1,902
+445
| +31% | +$14.1K | 0.18% | 95 |
|
|
2014
Q4 | $43K | Sell |
1,457
-8,290
| -85% | -$238K | 0.12% | 111 |
|
|
2014
Q3 | $273K | Sell |
9,747
-72
| -0.7% | -$2.02K | 0.74% | 33 |
|
|
2014
Q2 | $277K | Hold |
9,819
| – | – | 0.71% | 34 |
|
|
2014
Q1 | $299K | Sell |
9,819
-127
| -1% | -$3.79K | 0.81% | 29 |
|
|
2013
Q4 | $289K | Hold |
9,946
| – | – | 0.76% | 29 |
|
|
2013
Q3 | $271K | Hold |
9,946
| – | – | 0.79% | 28 |
|
|
2013
Q2 | $264K | Buy |
+9,946
| New | +$275K | 0.76% | 29 |
|
Other funds holding PFE
TIM
First National Bank Sioux Falls's PFE Position: Q1 2025 in Review
First National Bank Sioux Falls sold out of Pfizer (PFE) in Q1 2025, closing a stake of 8,050 shares — an estimated $214K sold.
First National Bank Sioux Falls first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $680K in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- First National Bank Sioux Falls reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- First National Bank Sioux Falls sold 8,050 Pfizer shares in Q1 2025, an estimated $214K.
- First National Bank Sioux Falls first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- First National Bank Sioux Falls's Pfizer position peaked at $680K in Q4 2021.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on First National Bank Sioux Falls's 13F filing for Q1 2025, filed 15 Apr 2025.